| Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis P Savola, T Kelkka, HL Rajala, A Kuuliala, K Kuuliala, S Eldfors, ... Nature communications 8 (1), 15869, 2017 | 117 | 2017 |
| Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population L Äyräväinen, M Leirisalo-Repo, A Kuuliala, K Ahola, R Koivuniemi, ... BMJ open 7 (1), e011916, 2017 | 110 | 2017 |
| Impact of rheumatic diseases on oral health and quality of life K Ahola, A Saarinen, A Kuuliala, M Leirisalo‐Repo, H Murtomaa, ... Oral diseases 21 (3), 342-348, 2015 | 63 | 2015 |
| Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study A Kuuliala, K Eberhardt, A Takala, H Kautiainen, H Repo, ... Annals of the rheumatic diseases 61 (3), 242-246, 2002 | 54 | 2002 |
| Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status L Äyräväinen, AM Heikkinen, A Kuuliala, K Ahola, R Koivuniemi, ... Annals of medicine 50 (4), 333-344, 2018 | 47 | 2018 |
| Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response M Palmroth, K Kuuliala, R Peltomaa, A Virtanen, A Kuuliala, A Kurttila, ... Frontiers in immunology 12, 738481, 2021 | 36 | 2021 |
| Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid … K Kuuliala, A Kuuliala, R Koivuniemi, S Oksanen, M Hämäläinen, ... PLoS One 10 (9), e0137385, 2015 | 32 | 2015 |
| Anti‐rheumatic medication and salivary MMP‐8, a biomarker for periodontal disease L Äyräväinen, AM Heikkinen, A Kuuliala, K Ahola, R Koivuniemi, ... Oral Diseases 24 (8), 1562-1571, 2018 | 30 | 2018 |
| Association of matrix metalloproteinases-7,-8 and-9 and TIMP-1 with disease severity in acute pancreatitis. A cohort study E Nukarinen, O Lindström, K Kuuliala, L Kylänpää, V Pettilä, ... PloS one 11 (8), e0161480, 2016 | 29 | 2016 |
| Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis M Holmström, R Koivuniemi, K Korpi, T Kaasalainen, M Laine, A Kuuliala, ... Clin Exp Rheumatol 34 (3), 416-23, 2016 | 29 | 2016 |
| Cord blood monocytes, neutrophils and lymphocytes from preterm and full‐term neonates show multiple aberrations in signalling profiles measured using phospho‐specific whole … I Nupponen, A Kuuliala, S Siitonen, H Repo, K Kuuliala Scandinavian journal of immunology 78 (5), 426-438, 2013 | 25 | 2013 |
| STAT6 and STAT1 pathway activation in circulating lymphocytes and monocytes as predictor of treatment response in rheumatoid arthritis K Kuuliala, A Kuuliala, R Koivuniemi, H Kautiainen, H Repo, ... PloS one 11 (12), e0167975, 2016 | 24 | 2016 |
| Activity of rheumatoid arthritis correlates with oral inflammatory burden L Äyräväinen, AM Heikkinen, A Kuuliala, K Ahola, R Koivuniemi, J Peltola, ... Rheumatology International 38, 1661-1669, 2018 | 20 | 2018 |
| Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis A Kuuliala, H Julkunen, L Paimela, R Peltomaa, H Kautiainen, H Repo, ... Rheumatology international 33, 2723-2729, 2013 | 20 | 2013 |
| Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab A Kuuliala, R Nissinen, H Kautiainen, H Repo, M Leirisalo-Repo Annals of the rheumatic diseases 65 (1), 26-29, 2006 | 17 | 2006 |
| Signalling profiles of blood leucocytes in sepsis and in acute pancreatitis in relation to disease severity K Kuuliala, AK Penttilä, KM Kaukonen, H Mustonen, A Kuuliala, J Oiva, ... Scandinavian journal of immunology 87 (2), 88-98, 2018 | 16 | 2018 |
| Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. A Kuuliala, M Leirisalo-Repo, T Möttönen, P Hannonen, M Nissilä, ... Clinical and experimental rheumatology 23 (2), 243-246, 2005 | 16 | 2005 |
| Impaired Akt phosphorylation in monocytes of patients with rheumatoid arthritis K Kuuliala, A Kuuliala, M Hämäläinen, R Koivuniemi, H Kautiainen, ... Scandinavian journal of immunology 85 (2), 155-161, 2017 | 15 | 2017 |
| Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis A Kuuliala, A Takala, S Siitonen, M Leirisalo‐Repo, H Repo Scandinavian journal of rheumatology 33 (1), 13-18, 2004 | 15 | 2004 |
| Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the … A Valli, K Kuuliala, A Virtanen, A Kuuliala, M Palmroth, R Peltomaa, ... Clinical and experimental immunology 210 (2), 141-150, 2022 | 14 | 2022 |
